News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Qualcomm TriCorder XPRIZE Selects 10 Finalists: Next Step Is for Devices to Diagnose Patients using Clinical Laboratory Test Technologies and Similar Diagnostic Tools

This new device will likely to be disruptive to clinical laboratories, as it can noninvasively diagnose at least 16 diseases and conditions

Pathologists and clinical laboratory managers who are fans of Star Trek will be interested to learn that a real-life “Tricorder” medical diagnostic device may be just around the corner. Officials of the XPRIZE organization recently announced 10 finalists who are competing to build a working Tricorder capable of monitoring multiple vital signs and identifying specific disease states.

Erik Viirre, M.D., Ph.D., Technical and Medical Director for the Qualcomm Tricorder XPRIZE, announced the 10 finalists last fall. Their devices may have a disruptive impact on medical laboratories, particularly if they lead to inexpensive, self-diagnostic tools that are capable of immediately running most lab tests.

Launched in January 2012 by the XPRIZE Foundation, which organizes international competitions to advance innovation, this life sciences contest to make the tricorder a reality is offering $10 million (£6m) in prize money. (See Dark Daily, “Pathologists and Clinical Lab Scientists: Design a Modern “Tricorder” and You Could Win $10 Million From the XPRIZE Foundation!,” March 22, 2013.) (more…)

Sequencing Developers’ Unprecedented Success Drives More Ambitious Goals For Genomics X Prize

New Genomic X PRIZE goals/subjects accelerate the drive toward personalized medicine

Swift improvements to the accuracy, speed, and lower cost of rapid gene sequencing have caused the sponsors of the globally-known X PRIZE to revamp their offer of a $10 million award to a team that is first to achieve a defined milestone in whole human genome sequencing.

Pathologists and clinical laboratory managers will be interested to learn how, last month, the X PRIZE Foundation announced a number of major changes to the formerly-named Archon Genomics X PRIZE. Most significantly, competition sponsors changed the subject from 100 genomes from unspecified donors, to genomes from 100 healthy centenarians.
(more…)

;